186 related articles for article (PubMed ID: 11325442)
1. Clinical stage IEA-IIEA orbital lymphomas: outcomes in the era of modern staging and treatment.
Pelloski CE; Wilder RB; Ha CS; Hess MA; Cabanillas FF; Cox JD
Radiother Oncol; 2001 May; 59(2):145-51. PubMed ID: 11325442
[TBL] [Abstract][Full Text] [Related]
2. Impact of involved field radiotherapy after CHOP-based chemotherapy on stage III-IV, intermediate grade and large-cell immunoblastic lymphomas.
Schlembach PJ; Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):1107-10. PubMed ID: 11072169
[TBL] [Abstract][Full Text] [Related]
3. Dose-response analysis for radiotherapy delivered to patients with intermediate-grade and large-cell immunoblastic lymphomas that have completely responded to CHOP-based induction chemotherapy.
Wilder RB; Tucker SL; Ha CS; Rodriguez MA; Hess MA; Cabanillas FF; Cox JD
Int J Radiat Oncol Biol Phys; 2001 Jan; 49(1):17-22. PubMed ID: 11163493
[TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for stage I primary orbital non-Hodgkin's lymphomas.
Erkal HS; Serin M; Sak SD; Cakmak A
Tumori; 1997; 83(5):822-5. PubMed ID: 9428915
[TBL] [Abstract][Full Text] [Related]
5. Curative radiotherapy for primary orbital lymphoma.
Bhatia S; Paulino AC; Buatti JM; Mayr NA; Wen BC
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):818-23. PubMed ID: 12377334
[TBL] [Abstract][Full Text] [Related]
6. Orbital lymphoma: radiotherapy outcome and complications.
Stafford SL; Kozelsky TF; Garrity JA; Kurtin PJ; Leavitt JA; Martenson JA; Habermann TM
Radiother Oncol; 2001 May; 59(2):139-44. PubMed ID: 11325441
[TBL] [Abstract][Full Text] [Related]
7. Orbital lymphoma: diagnostic approach and treatment outcome.
Eckardt AM; Lemound J; Rana M; Gellrich NC
World J Surg Oncol; 2013 Mar; 11():73. PubMed ID: 23506357
[TBL] [Abstract][Full Text] [Related]
8. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
9. Radiation therapy for primary orbital lymphoma.
Chao CK; Lin HS; Devineni VR; Smith M
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(4):929-34. PubMed ID: 7860408
[TBL] [Abstract][Full Text] [Related]
10. Cyclophosphamide, doxorubicin, vincristine and prednisone chemotherapy and radiotherapy for stage I intermediate or high grade non-Hodgkin's lymphomas: results of a strategy that adapts radiotherapy dose to the response after chemotherapy.
Krol AD; Berenschot HW; Doekharan D; Henzen-Logmans S; van der Holt B; van 't Veer MB
Radiother Oncol; 2001 Mar; 58(3):251-5. PubMed ID: 11230885
[TBL] [Abstract][Full Text] [Related]
11. The impact of radiotherapy dose and other treatment-related and clinical factors on in-field control in stage I and II non-Hodgkin's lymphoma.
Kamath SS; Marcus RB; Lynch JW; Mendenhall NP
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):563-8. PubMed ID: 10348285
[TBL] [Abstract][Full Text] [Related]
12. Radiotherapy of indolent orbital lymphomas : Two radiation concepts.
König L; Stade R; Rieber J; Debus J; Herfarth K
Strahlenther Onkol; 2016 Jun; 192(6):414-21. PubMed ID: 27160291
[TBL] [Abstract][Full Text] [Related]
13. A retrospective analysis of different modalities for treatment of primary orbital non-Hodgkin's lymphomas.
Esik O; Ikeda H; Mukai K; Kaneko A
Radiother Oncol; 1996 Jan; 38(1):13-8. PubMed ID: 8850421
[TBL] [Abstract][Full Text] [Related]
14. Ocular adnexal lymphoma: clinical behavior of distinct World Health Organization classification subtypes.
Fung CY; Tarbell NJ; Lucarelli MJ; Goldberg SI; Linggood RM; Harris NL; Ferry JA
Int J Radiat Oncol Biol Phys; 2003 Dec; 57(5):1382-91. PubMed ID: 14630277
[TBL] [Abstract][Full Text] [Related]
15. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy and radiotherapy for non-Hodgkin's lymphomas of the nasal cavity].
Nie DH; Hu WH; Gao YH; Wu Y; Zhang SP
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):312-4. PubMed ID: 15312373
[TBL] [Abstract][Full Text] [Related]
17. Results of radiotherapy and combined modality treatment in early stage high grade non-Hodgkin's lymphoma.
Frank C; Flentje M; Goldschmidt H; Hunstein W; Wannenmacher M
Strahlenther Onkol; 1994 Jul; 170(7):383-90. PubMed ID: 8052937
[TBL] [Abstract][Full Text] [Related]
18. A systematic overview of radiation therapy effects in non-Hodgkin's lymphoma.
Gustavsson A; Osterman B; Cavallin-Ståhl E
Acta Oncol; 2003; 42(5-6):605-19. PubMed ID: 14596518
[TBL] [Abstract][Full Text] [Related]
19. Outcome and prognostic factors in orbital lymphoma: a Rare Cancer Network study on 90 consecutive patients treated with radiotherapy.
Martinet S; Ozsahin M; Belkacémi Y; Landmann C; Poortmans P; Oehlere C; Scandolaro L; Krengli M; Maingon P; Miralbell R; Studer G; Chauvet B; Marnitz S; Zouhair A; Mirimanoff RO
Int J Radiat Oncol Biol Phys; 2003 Mar; 55(4):892-8. PubMed ID: 12605966
[TBL] [Abstract][Full Text] [Related]
20. Indolent stage IE non-Hodgkin's lymphoma of the orbit: results after primary radiotherapy.
Bischof M; Zierhut D; Neuhof D; Karagiozidis M; Treiber M; Roeder F; Debus J; Krempien R
Ophthalmologica; 2007; 221(5):348-52. PubMed ID: 17728558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
